Please check your internet connection and try again.
# Walethmade bromide (Valethamate bromide)
## Overview
Valethamate bromide is a quaternary ammonium anticholinergic agent with muscarinic antagonist properties. It acts as a spasmolytic, exerting a direct musculotropic effect on smooth muscle fibers in addition to its anticholinergic activity.
## Primary Indications
Primarily used for smooth muscle relaxation in gastrointestinal spasms, biliary colic, and urinary tract spasms. In some international jurisdictions (not FDA-approved), it has been used as a cervical dilator during labor.
## Adult Dosing
* **Oral/IM/IV:** 8 mg to 16 mg every 6 to 8 hours as needed.
* **Maximum Dose:** Generally 48 mg per 24 hours.
* *Note: Dosing varies significantly by regional clinical practice and specific product formulation. Always refer to your local hospital formulary or the manufacturer's package insert.*
## Pediatric Dosing
* **Safety/Efficacy:** Not well-established in pediatric populations. Use is generally avoided unless under specialized supervision. If calculated based on clinical judgment: 0.1 mg/kg to 0.2 mg/kg per dose.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standardized guidelines exist. Use with extreme caution; dosage reduction is indicated due to reduced clearance of quaternary ammonium compounds.
## Contraindications
* Hypersensitivity to the drug.
* Glaucoma (narrow-angle).
* Prostatic hypertrophy (risk of urinary retention).
* Pyloric obstruction or paralytic ileus.
* Myasthenia gravis.
* Tachycardia/cardiac arrhythmias.
## Adverse Effects
* **Anticholinergic:** Xerostomia (dry mouth), blurred vision (mydriasis/cycloplegia), tachycardia, urinary retention, and constipation.
* **CNS:** Dizziness, confusion (especially in geriatrics), or headache.
* **Dermatologic:** Flushing or anhidrosis.
## Key Drug Interactions
* **Other Anticholinergics:** Additive effects (e.g., antihistamines, tricyclic antidepressants, antipsychotics) increasing the risk of delirium and urinary retention.
* **Potassium Chloride:** Solid oral dosage forms may have enhanced mucosal ulceration risk when taken with anticholinergics that decrease transit time.
## Monitoring
* Monitor heart rate for new-onset tachycardia.
* Assess for urinary output/distension.
* Assess mental status changes, particularly in patients >65 years.
## Clinical Pearls
* As a quaternary ammonium compound, it does not readily cross the blood-brain barrier compared to tertiary amines (like atropine), theoretically resulting in fewer central nervous system side effects, though caution remains necessary.
* Physicians should verify if the patient is using the drug for obstetric use (cervical ripening), as this is a high-risk indication requiring specialized fetal monitoring.
***
**Educational Disclaimer:** This information is intended for educational purposes for healthcare professionals. Valethamate bromide is not an FDA-approved medication in the United States. Always verify current prescribing information, local clinical guidelines, and contraindications via the specific manufacturer’s documentation or your institution’s pharmacy department before prescribing or administering.
